IRIX
IRIDEX CORPCompany Information
- Company Name
- IRIDEX CORP
- CIK
- CIK0001006045
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- IRIX: Nasdaq
- Fiscal Year End
- January 03
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3845
- SIC Description
- Electromedical & Electrotherapeutic Apparatus
- Ticker
- IRIX
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-09-16
- Last sale
- —
- Shares purchased (TTM)
- 158,710
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 2,170,249
- Shares outstanding
- 17,418,000
- Ownership
- 12.46%
Earnings Market Reaction
- Filing date
- 2026-08-18
- Price on filing date
- —
- 1-month reaction
- …
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 5 | 5 | 6 | 6 | 7 | 7 | 2 | 4 | 4 | 5 | 7 | 8 | ||||||
| Accounts Receivable Net Current | 6 | 7 | 8 | 7 | 7 | 7 | 6 | 6 | 6 | 7 | 7 | 6 | ||||||
| Inventory Net | 10 | 9 | 8 | 7 | 8 | 10 | 11 | 11 | 11 | 11 | 10 | 10 | ||||||
| Prepaid Expense And Other Assets Current | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | ||||||
| Assets Current | 24 | 25 | 25 | 24 | 27 | 29 | 24 | 24 | 25 | 28 | 27 | 27 | ||||||
| Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | ||||||
| Finite Lived Intangible Assets Net | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | ||||||
| Goodwill | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Operating Lease Right Of Use Asset | 0 | 0 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | ||||||
| Other Assets Noncurrent | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | ||||||
| Assets | 27 | 28 | 29 | 28 | 32 | 34 | 29 | 30 | 31 | 34 | 34 | 35 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 7 | 6 | 5 | 4 | 5 | 6 | 7 | 6 | 8 | 8 | 4 | 3 | ||||||
| Employee Related Liabilities Current | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | ||||||
| Accrued Liabilities Current | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 2 | 1 | ||||||
| Convertible Notes Payable Current | - | - | 0 | 0 | 0 | 0 | 2 | 1 | - | - | 0 | - | ||||||
| Product Warranty Accrual Classified Current | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Other Liabilities Current | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | ||||||
| Contract With Customer Liability Current | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | ||||||
| Operating Lease Liability Current | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Liabilities Current | 13 | 13 | 13 | 12 | 14 | 15 | 17 | 16 | 16 | 16 | 13 | 10 | ||||||
Liabilities Noncurrent | ||||||||||||||||||
| Contract With Customer Liability Noncurrent | 6 | 6 | 7 | 7 | 8 | 8 | 8 | 9 | 9 | 10 | 10 | 10 | ||||||
| Product Warranty Accrual Noncurrent | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Operating Lease Liability Noncurrent | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | ||||||
| Convertible Long Term Notes Payable | 4 | 4 | 4 | 4 | 4 | 4 | 1 | 1 | - | - | 0 | - | ||||||
| Other Liabilities Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities | 24 | 24 | 24 | 24 | 26 | 27 | 27 | 28 | 27 | 28 | 25 | 23 | ||||||
Stockholders Equity | ||||||||||||||||||
| Preferred Stock Value | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital Common Stock | 92 | 92 | 91 | 91 | 91 | 90 | 90 | 90 | 89 | 89 | 88 | 88 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -0 | -0 | -0 | -0 | -0 | 0 | 0 | 0 | 0 | -0 | -0 | -0 | ||||||
| Retained Earnings Accumulated Deficit | -94 | -93 | -92 | -92 | -91 | -90 | -88 | -87 | -85 | -83 | -79 | -76 | ||||||
| Stockholders Equity | 4 | 5 | 5 | 5 | 6 | 1 | 2 | 3 | 4 | 6 | 10 | 12 | ||||||
| Preferred Stock Par Or Stated Value Per Share | - | - | - | - | - | - | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | ||||||
| Liabilities And Stockholders Equity | 27 | 28 | 29 | 28 | 32 | 34 | 29 | 30 | 31 | 34 | 34 | 35 | ||||||
| Allowance For Doubtful Accounts Receivable Current | - | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
| Series B Convertible Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | ||||||
| Preferred Stock Shares Issued | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Authorized | - | - | - | - | 2 | - | 2 | 2 | 2 | 2 | 2 | 2 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | ||||||
| Common Stock Shares Authorized | 64 | 64 | 64 | 64 | 64 | 30 | 64 | 30 | 30 | 30 | 30 | 30 | ||||||
| Common Stock Shares Issued | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 16 | 16 | 16 | 16 | ||||||
| Shares Outstanding | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 16 | 16 | 16 | 16 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialIRIDEX CORP (IRIX) — SEC Financial Statements & Analysis
IRIDEX CORP (IRIX) is a electromedical & electrotherapeutic apparatus company, incorporated in DE. IRIDEX CORP trades on Nasdaq as: IRIX. IRIDEX CORP (IRIX)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-18. Based on that filing, IRIDEX CORP carries a market cap of $20.03M, a P/E ratio of -5.65x, a P/B ratio of 5.50x, a P/S ratio of 0.39x, an enterprise value of $19.15M, and an EV/EBITDA multiple of -8.21x. On profitability, it posts a gross margin of 35.92%, an operating margin of -5.39%, a net margin of -6.88%, a Return on Equity (ROE) of -73.15%, a Return on Assets (ROA) of -12.06%, and a Return on Invested Capital (ROIC) of -71.84%. Per share, it reports EPS of $-0.20, diluted EPS of $-0.20, free cash flow per share of $-0.11, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 3.68% year-over-year, net income growth of -34.88% year-over-year, and EPS growth of -37.22% year-over-year. On the balance sheet, it maintains a current ratio of 1.82x, a quick ratio of 0.89x, working capital of $10.79M, a debt-to-equity ratio of 6.49x, a debt ratio of 0.87, free cash flow of $-2.00M (TTM), and net debt of $-885.00K. Figures sourced from SEC EDGAR.
- Market Cap
- $20.03M
- P/E TTM
- -5.65x
- EPS TTM
- $-0.20
- P/B TTM
- 5.50x
- ROE TTM
- -73.15%
- ROA TTM
- -12.06%
- Debt To Equity
- 6.49x
- Free Cash Flow TTM
- $-2.00M
- Net Revenue TTM Growth 1Y
- 3.68%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is IRIDEX CORP in?
IRIDEX CORP (IRIX) operates in the Electromedical & Electrotherapeutic Apparatus industry.
What exchange does IRIX trade on?
IRIDEX CORP (IRIX) trades on the Nasdaq.
Where is IRIDEX CORP incorporated?
IRIDEX CORP is incorporated in DE.
When was IRIDEX CORP (IRIX)'s most recent SEC filing?
IRIDEX CORP (IRIX)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-18.
What is IRIX's market cap?
IRIDEX CORP (IRIX) has a market capitalization of $20.03M as of 2026-06-30.
What is IRIX's EPS (earnings per share)?
IRIDEX CORP (IRIX)'s trailing twelve month EPS is $-0.20 as of 2026-06-30.
What is IRIX's ROE (return on equity)?
IRIDEX CORP (IRIX)'s trailing twelve month Return on Equity (ROE) is -73.15% as of 2026-06-30.
What is IRIX's ROA (return on assets)?
IRIDEX CORP (IRIX)'s trailing twelve month Return on Assets (ROA) is -12.06% as of 2026-06-30.
What is IRIX's ROIC (return on invested capital)?
IRIDEX CORP (IRIX)'s trailing twelve month Return on Invested Capital (ROIC) is -71.84% as of 2026-06-30.
What is IRIX's EV/EBITDA?
IRIDEX CORP (IRIX)'s trailing twelve month EV/EBITDA is -8.21x as of 2026-06-30.